Thomas Andrew Davis Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Thomas Andrew Davis.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Thomas Andrew Davis. Thomas Andrew Davis is an Executive VP & CMO in Celldex Therapeutics, Inc. ($AVAN) and a Chief Medical Officer in GENVEC INC ($GNVC) and a CHIEF MEDICAL OFFICER in GENOCEA BIOSCIENCES, INC. ($GNCA).

Address: 65 WEST WATKINS MILL ROAD GAITHERSBURG 20878United States

Companies in which Thomas Andrew Davis is an Insider

Celldex Therapeutics, Inc.

Trading Symbol: CLDX
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Thomas Andrew Davis: Executive VP & CMO
Holdings: 0 shares
Latest Transaction: Jun 16 2017

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

GENOCEA BIOSCIENCES, INC.

Trading Symbol: GNCA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Thomas Andrew Davis: CHIEF MEDICAL OFFICER
Holdings: 31,250 shares
Current Value: $140,938
Latest Transaction: Mar 17 2021
$GNCA Market Capitalization: $129.13M
$GNCA Previous Close: $4.51

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

GENVEC INC

Trading Symbol: GNVC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Thomas Andrew Davis: Chief Medical Officer
Holdings: 5,000 shares
Current Value: $32,000
Latest Transaction: Jan 26 2006
$GNVC Market Capitalization: $14.75M
$GNVC Previous Close: $6.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Thomas Andrew Davis

Sentiment: All, CLDX, GNCA, GNVC

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Davis Thomas AndrewCHIEF MEDICAL OFFIC ...Option ExerciseA0.00100,0000100,000
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Davis Thomas AndrewCHIEF MEDICAL OFFIC ...Option ExerciseA0.00100,0000100,000
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Davis Thomas AndrewCHIEF MEDICAL OFFIC ...Option ExerciseA3.0193,750282,18893,750
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Davis Thomas AndrewCHIEF MEDICAL OFFIC ...Option ExerciseA3.0193,750282,18893,750
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Davis Thomas AndrewCHIEF MEDICAL OFFIC ...GrantA0.0031,250031,2500 to 31.3 K
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Davis Thomas AndrewCHIEF MEDICAL OFFIC ...GrantA0.0031,250031,2500 to 31.3 K
Jun 02 2020GNCAGENOCEA BIOSCIENCE ...Davis Thomas AndrewCHIEF MEDICAL OFFIC ...Option ExerciseA2.7224,93867,83124,938

View all Thomas Andrew Davis insider transactions.

What Should I Do When Insiders Are Selling Stock?

It's often said that insider selling can be a hint that they know that their stock is about to underperform the market. Even though this is true in some cases, it's also true that insider selling is frequently simply behind financial reasons of the insiders and have no connection with the company's prospects. More ...

Are IPOs Interesting for Small Investors?

Initial Public Offering is the first sale of stock by a privately owned company to the public. Companies negotiate a sale of their stock to an investment banker or several bankers that act as an underwriter for the offering. More ...

What Happens When a Company Gets Delisted?

When listed on a major exchange, such as the NYSE or Nasdaq, the companies and their stock have to meet several listing requirements on stock price, trading volume, capitalization, disclosure of material information or financial reporting. More ...

Contact us | Follow us on Twitter